Provided by Tiger Fintech (Singapore) Pte. Ltd.

Olema Pharmaceuticals, Inc.

5.37
-0.0400-0.74%
Post-market: 5.30-0.0692-1.29%17:12 EDT
Volume:772.12K
Turnover:4.20M
Market Cap:367.42M
PE:-2.76
High:5.66
Open:5.35
Low:5.27
Close:5.41
Loading ...
Jun 13, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 19, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 19, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 19, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Correspondence

Form CORRESP - Correspondence
Jan 13, 2025

Correspondence

Form CORRESP - Correspondence
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Dec 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities